MX2007007391A - Compuestos que interactuan con canales de iones, en particular con canales de iones de la familia kv. - Google Patents

Compuestos que interactuan con canales de iones, en particular con canales de iones de la familia kv.

Info

Publication number
MX2007007391A
MX2007007391A MX2007007391A MX2007007391A MX2007007391A MX 2007007391 A MX2007007391 A MX 2007007391A MX 2007007391 A MX2007007391 A MX 2007007391A MX 2007007391 A MX2007007391 A MX 2007007391A MX 2007007391 A MX2007007391 A MX 2007007391A
Authority
MX
Mexico
Prior art keywords
sup
compounds
ion channel
relates
channel activity
Prior art date
Application number
MX2007007391A
Other languages
English (en)
Inventor
Dirk Leysen
Petra Blom
Eric Pierre Paul Rene Fourmaintraux
Titus Jan Kaletta
Jan Octaaf De Kerpel
Original Assignee
Devgen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devgen Nv filed Critical Devgen Nv
Priority claimed from PCT/EP2005/013715 external-priority patent/WO2006066879A2/en
Publication of MX2007007391A publication Critical patent/MX2007007391A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

La presente invencion se refiere a compuestos que interactuan con canales de iones. En particular, la invencion se refiere a compuestos que tienen la Formula (I), (II), (III) o (IV) estructural, estereoisomeros, tautomeros, racemicos, profarmacos, metabolitos de los mismos, o una sal y/o solvato farmaceuticamente aceptables de los mismos, las Formula (I), (II), (III) o (IV), en donde X1, X2, Y, Z, W, R1, R8, R9, R10, L, A, z, y n tienen el significado como se definio en la reivindicacion 1. La invencion tambien se refiere a metodos para preparar los compuestos, a composiciones farmaceuticas que comprenden los compuestos, y al uso de los compuestos y metodos para tratamiento del cuerpo humano y animal.
MX2007007391A 2004-12-21 2005-12-20 Compuestos que interactuan con canales de iones, en particular con canales de iones de la familia kv. MX2007007391A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US63766004P 2004-12-21 2004-12-21
EP04447288 2004-12-21
US68691305P 2005-06-03 2005-06-03
EP05077173 2005-09-22
PCT/EP2005/013715 WO2006066879A2 (en) 2004-12-21 2005-12-20 Compounds with kv4 ion channel activity

Publications (1)

Publication Number Publication Date
MX2007007391A true MX2007007391A (es) 2008-03-13

Family

ID=39521323

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007391A MX2007007391A (es) 2004-12-21 2005-12-20 Compuestos que interactuan con canales de iones, en particular con canales de iones de la familia kv.

Country Status (4)

Country Link
JP (1) JP2008524294A (es)
BR (1) BRPI0517190A (es)
IL (1) IL183301A0 (es)
MX (1) MX2007007391A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2611804A1 (en) 2010-09-03 2013-07-10 Forma TM, LLC. Novel compounds and compositions for the inhibition of nampt

Also Published As

Publication number Publication date
IL183301A0 (en) 2007-09-20
JP2008524294A (ja) 2008-07-10
BRPI0517190A (pt) 2008-06-17

Similar Documents

Publication Publication Date Title
WO2006066879A3 (en) Compounds with kv4 ion channel activity
WO2007138110A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
WO2006018182A8 (en) Combinations for the treatment of diseases involving cell proliferation
TW200517109A (en) Substituted pyridinones
WO2007117465A3 (en) Indazole compounds
MY148125A (en) Compounds
WO2005023759A3 (en) Heterocyclic inhibitors of mek and methods of use thereof
RS20050732A (en) Substituted pyrimidinones
MX2007013624A (es) Inhibidores de proteina cinasa.
UA92637C2 (en) Pyridine[3,4-b]pyrazinones
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
GB0112348D0 (en) Compounds
HK1075205A1 (en) Combination of selected opioids with muscarine antagonists for treating urinary incontinence
TW200606164A (en) New compounds
TW200637552A (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
MX2008008556A (es) Derivados de triterpenoquinonas y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
TW200800984A (en) New compounds
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
GEP20074127B (en) Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
UA92463C2 (ru) Производные пиримидинсульфонамида как модуляторы рецепторов хемокина

Legal Events

Date Code Title Description
FA Abandonment or withdrawal